Literature DB >> 2231918

Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.

R L Deresiewicz1, R M Stone, J C Aster.   

Abstract

We describe a fatal case of disseminated mycobacteriosis after intravesical bacillus Calmette-Guerin immunotherapy. We summarize the prior safety record of this therapeutic modality, discuss local and systemic pathophysiological mechanisms by which dissemination might have occurred, and review the reported clinical experience with antituberculous chemotherapy for significant bacillus Calmette-Guerin infection. Finally, we offer suggestions for prophylaxis of certain patients with a history of exposure to intravesical bacillus Calmette-Guerin.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2231918     DOI： 10.1016/s0022-5347(17)39732-x

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  11 in total

1.  Pulmonary tuberculosis due to bacille Calmette-Guérin.

Authors:  D Kirsten; U Rieger; K H Schröder; A Böhle; H Magnussen
Journal:  Clin Investig       Date:  1993-10

Review 2.  Medical management of patients with refractory carcinoma in situ of the bladder.

Authors:  J C Kim; G D Steinberg
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.

Authors:  Petar Duvnjak; Mario Laguna
Journal:  J Radiol Case Rep       Date:  2016-08-31

4.  Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment.

Authors:  Bart Santbergen; P H W E Vriens; W C M de Lange; M E E Van Kasteren
Journal:  BMJ Case Rep       Date:  2013-01-25

5.  Denovo urothelial carcinoma of the upper and lower urinary tract in kidney--transplant patients with end-stage analgesic nephropathy.

Authors:  W F Thon; V Kliem; M C Truss; P Anton; M Kuczyk; C G Stief; R Brunkhorst
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 6.  BCG in the treatment of superficial cancer of the bladder: a review.

Authors:  S Friberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

7.  Management of Bladder Cancer following Solid Organ Transplantation.

Authors:  Jeffrey J Tomaszewski; Jeffrey A Larson; Marc C Smaldone; Matthew H Hayn; Stephen V Jackman
Journal:  Adv Urol       Date:  2011-04-18

Review 8.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 9.  Mycobacterium bovis-induced Aneurysm after Intravesical Bacillus Calmette-Guérin Therapy: A Case Study and Literature Review.

Authors:  Yoshitsugu Higashi; Shigeki Nakamura; Kento Kidani; Kaoru Matumoto; Koyomi Kawago; Junko Isobe; Junichi Kanatani; Yukio Kawagishi; Ippei Sakamaki; Yoshihiro Yamamoto
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

10.  Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer.

Authors:  Shingo Tsuji; Xuguang Chen; Bryan Hancock; Veronica Hernandez; Barbara Visentin; Katherine Reil; Roger Sabbadini; Matthew Giacalone; W T Godbey
Journal:  Mol Ther Oncolytics       Date:  2016-03-16       Impact factor: 7.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.